Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Market Cap	5.50B -23.8%
Revenue (ttm)	1.51B -6.1%
Net Income	397.22M -20.6%
EPS	0.47 -20.6%
Shares Out	837.10M
PE Ratio	13.85
Forward PE	12.40
Dividend	0.37 (5.63%)
Ex-Dividend Date	Jun 12, 2026

Volume	429,000
Open	6.44
Previous Close	6.50
Day's Range	6.44 - 6.63
52-Week Range	6.21 - 9.72
Beta	0.34
Analysts	Buy
Price Target	10.25 (+56.01%)
Earnings Date	Aug 10, 2026

About HKG:3613

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1669
• Employees: 780
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3613

Financial Performance

In 2025, HKG:3613's revenue was 1.51 billion, a decrease of -6.10% compared to the previous year's 1.61 billion. Earnings were 397.22 million, a decrease of -20.60%.

Analyst Summary

According to 2 analysts, the average rating for 3613 stock is "Buy." The 12-month stock price target is $10.25, which is an increase of 56.01% from the latest price.

Price Target

$10.25

(56.01% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error